2
RESEARCH METHODOLOGY
31
5
MARKET OVERVIEW
Booming demand for clean-label postbiotics driven by wellness trends and AI-powered personalization.
49
5.2
MACROECONOMIC INDICATORS
5.2.1
RISING DEMAND FOR NUTRACEUTICAL AND FUNCTIONAL FOOD
5.2.2
SUSTAINABILITY AND CLEAN LABEL TRENDS
5.3.1.1
Rising consumer awareness of gut health and overall wellness
5.3.1.2
Increasing preference for natural, clean-label ingredients
5.3.1.3
Increasing incidence of digestive disorders and chronic health issues
5.3.1.4
Growing demand for functional food and beverages
5.3.2.1
Competition from established alternatives like probiotics and prebiotics
5.3.2.2
Unclear clinical recommendations and prescription practices
5.3.2.3
Side effects and limited clinical safety data
5.3.3.1
Therapeutic applications in nutrition
5.3.3.2
Technological and economic advantages over probiotics
5.3.3.3
Emerging applications in food preservation
5.3.3.4
Increasing R&D activities for postbiotics
5.3.4.1
Yield optimization, storage, and stability
5.3.4.2
Regulatory uncertainty and lack of standardization
5.3.4.3
High R&D and production costs
5.4
IMPACT OF GEN AI ON FOOD & BEVERAGE INGREDIENTS/ADDITIVES
5.4.1
USE OF GEN AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES
5.4.2
CASE STUDIES FOR GENERATIVE AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES
5.4.2.1
Kerry Trendspotter leveraged AI and ML to analyze consumer-generated social media content, identifying and predicting food trends
5.4.2.2
IFF partners with Salus Optima to create personalized nutrition platform using AI to offer customized dietary recommendations based on metabolic health
5.4.2.3
Ingredion utilized cloud-based data analytics, AI, and cloud technology to address challenges in F&B industry
5.4.3
IMPACT OF GENERATIVE AI/AI ON POSTBIOTICS MARKET
5.4.4
ADJACENT ECOSYSTEM WORKING ON GENERATIVE AI
6
INDUSTRY TRENDS
US tariffs reshape global postbiotics market, sparking innovation and altering trade dynamics.
66
6.2
IMPACT OF 2025 US TARIFF – POSTBIOTICS MARKET
6.2.3
DISRUPTION IN MICROBIAL INGREDIENTS INDUSTRY & POSTBIOTICS
6.2.4
PRICE IMPACT ANALYSIS
6.2.5
IMPACT ON COUNTRY/REGION
6.2.6
IMPACT ON END-USE INDUSTRIES
6.3.1
RESEARCH & PRODUCT DEVELOPMENT
6.3.2
RAW MATERIAL SOURCING
6.3.3
PRODUCTION & PROCESSING
6.4.1
IMPORT SCENARIO OF HS CODE 3002
6.4.2
EXPORT SCENARIO OF HS CODE 3002
6.5.1.1
Heating-based inactivation technologies
6.5.1.2
Extraction technologies
6.5.1.3
Identification and characterization technologies
6.5.2
COMPLEMENTARY TECHNOLOGIES
6.5.2.1
Genomic and metabolomic profiling
6.5.2.2
Bioinformatics and machine learning
6.5.2.3
Bioprocess monitoring and automation
6.5.3
ADJACENT TECHNOLOGIES
6.5.3.1
Microbiome diagnostics: 16S rRNA sequencing
6.6.1
AVERAGE SELLING PRICE OF POSTBIOTIC PRODUCTS, BY KEY PLAYER
6.6.2
AVERAGE SELLING PRICE TREND, BY REGION
6.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
6.10
KEY CONFERENCES AND EVENTS, 2025–2026
6.11
REGULATORY LANDSCAPE
6.11.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.2
REGULATORY FRAMEWORK
6.12
PORTER’S FIVE FORCES ANALYSIS
6.12.1
THREAT OF NEW ENTRANTS
6.12.2
THREAT OF SUBSTITUTES
6.12.3
BARGAINING POWER OF SUPPLIERS
6.12.4
BARGAINING POWER OF BUYERS
6.12.5
INTENSITY OF COMPETITIVE RIVALRY
6.13
KEY STAKEHOLDERS AND BUYING CRITERIA
6.13.1
KEY STAKEHOLDERS IN BUYING PROCESS
6.14.1
DSM-FIRMENICH’S STRATEGIC LEAP INTO POSTBIOTICS THROUGH ADARE BIOME ACQUISITION
6.14.2
ADM’S USD 30 MILLION INVESTMENT IN PROBIOTIC & POSTBIOTIC PRODUCTION FACILITY IN SPAIN
6.14.3
CARGILL’S ACQUISITION AND SCALE-UP OF EPICOR POSTBIOTIC INGREDIENT
6.15
INVESTMENT AND FUNDING SCENARIO
7
POSTBIOTICS MARKET, BY FUNCTION
Market Size & Growth Rate Forecast Analysis
99
8
POSTBIOTIC MARKET, BY MANUFACTURING TECHNOLOGY
Market Size & Growth Rate Forecast Analysis
103
8.5
OTHER MANUFACTURING TECHNOLOGIES
9
POSTBIOTICS MARKET, BY SOURCE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Tons | 16 Data Tables
106
9.2.1
VERSATILITY AND WIDE-RANGING APPLICATIONS IN FUNCTIONAL FOOD, SUPPLEMENTS, AND THERAPEUTIC PRODUCTS TO DRIVE DEMAND
9.3.1
RISING UTILIZATION IN ANIMAL HEALTHCARE AND FEED APPLICATIONS TO DRIVE MARKET
9.3.2
SACCHAROMYCES CEREVISIAE
9.3.3
SACCHAROMYCES BOULARDII
10
POSTBIOTICS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 12 Data Tables
115
10.2
FUNCTIONAL FOOD & BEVERAGES
10.2.1
INCREASING FOCUS ON GUT AND IMMUNE HEALTH TO BOOST ADOPTION OF POSTBIOTIC INGREDIENTS
10.3.1
RISING EMPHASIS ON GUT AND IMMUNE HEALTH TO DRIVE DEMAND FOR POSTBIOTICS IN DIETARY SUPPLEMENTS
10.4.1
GROWING ADOPTION OF POSTBIOTICS IN ANIMAL FEED FOR IMPROVED HEALTH AND PERFORMANCE
10.5
COSMETICS & PERSONAL CARE
10.5.1
DEMAND FOR MICROBIOME-FRIENDLY FORMULATIONS IN COSMETICS & PERSONAL CARE TO DRIVE MARKET
10.6.1
THERAPEUTIC POTENTIAL TO DRIVE DEMAND FOR POSTBIOTICS IN PHARMACEUTICALS
11
POSTBIOTICS MARKET, BY FORM
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
123
11.2.1
NEED FOR ENHANCED STABILITY, SHELF LIFE, AND APPLICATION FLEXIBILITY TO DRIVE DEMAND
11.3.1
EASE OF INCORPORATION INTO FUNCTIONAL BEVERAGES AND FERMENTED PRODUCTS TO DRIVE DEMAND
12
POSTBIOTICS MARKET, BY REGION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Tons | 112 Data Tables
128
12.2.1.1
Clinical innovation and evolving health needs to steer market trends
12.2.2.1
Health Canada approvals and pediatric research to drive market
12.2.3.1
Rising interest in immune-supportive and gut-health formulations to drive market
12.3.1.1
Robust life sciences infrastructure and advanced industrial fermentation capabilities to drive market
12.3.2.1
Growing interest in incorporating postbiotic ingredients into mainstream food and beverage products to boost market
12.3.3.1
Fermentation expertise and growing interest in scientifically backed microbial ingredients to drive market
12.3.4.1
Increasing focus of key startups on fermentation technologies to drive market
12.3.5.1
Strategic investments in functional ingredient space to drive market
12.4.1.1
Growing consumer interest in gut health, functional foods, and wellness ingredients to drive market
12.4.2.1
Emphasis on gut health and functional nutrition to drive market
12.4.3.1
Consumer shift toward functional and preventive nutrition products to drive market
12.4.4
AUSTRALIA & NEW ZEALAND
12.4.4.1
Increasing consumer demand for functional foods, clean-label ingredients, and gut health solutions to drive market
12.4.5
REST OF ASIA PACIFIC
12.5.1.1
Rising consumer awareness around gut health, immunity, and functional nutrition to drive market
12.5.2.1
Health and sustainability drives, including Vision 2030, to increase postbiotics adoption
12.5.3.1
Rising focus on gut health and preventive nutrition to drive market
13
COMPETITIVE LANDSCAPE
Analyze market leaders' strategies and valuations to identify emerging industry stars and competitive dynamics.
173
13.2
KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–JULY 2025
13.3
REVENUE ANALYSIS, 2022–2024
13.4
MARKET SHARE ANALYSIS, 2024
13.5
COMPANY VALUATION AND FINANCIAL METRICS
13.6
BRAND/PRODUCT COMPARISON
13.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
13.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
13.7.5.1
Company footprint
13.7.5.2
Regional footprint
13.7.5.3
Source footprint
13.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
13.8.1
PROGRESSIVE COMPANIES
13.8.2
RESPONSIVE COMPANIES
13.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
13.8.5.1
Detailed list of key startups/SMEs
13.8.5.2
Competitive benchmarking of key startups/SMEs
13.9
COMPETITIVE SCENARIO
14
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
197
14.1.1.1
Business overview
14.1.1.2
Products/Services/Solutions offered
14.1.1.3
Recent developments
14.1.2
CARGILL, INCORPORATED
14.1.5
ASSOCIATED BRITISH FOODS PLC
14.1.8
INTERNATIONAL FLAVORS & FRAGRANCES INC.
14.1.10
PHILEO BY LESAFFRE
14.1.12
SAMI-SABINSA GROUP
14.1.13
CJ CHEILJEDANG CORP.
14.1.14
MORINAGA MILK INDUSTRY CO., LTD.
14.1.15
KIRIN HOLDINGS COMPANY, LIMITED
14.2.1
BIOTENOVA SDN. BHD.
14.2.2
BIOPROX HEALTHCARE
14.2.5
NUTRIGNOMIX SDN. BHD.
14.2.8
VERDESIAN LIFE SCIENCES
15
ADJACENT & RELATED MARKETS
256
15.3
FUNCTIONAL FOOD INGREDIENTS MARKET
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3
CUSTOMIZATION OPTIONS
TABLE 1
USD EXCHANGE RATES, 2020–2024
TABLE 2
POSTBIOTICS MARKET SNAPSHOT, 2025 VS. 2030 (USD MILLION)
TABLE 3
US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 4
EXPECTED IMPACT LEVEL ON TARGET INGREDIENTS WITH RELEVANT HS CODES DUE TO US TARIFF IMPACT
TABLE 5
EXPECTED TARIFF IMPACT ON END-USE INDUSTRIES: POSTBIOTICS MARKET
TABLE 6
IMPORT SCENARIO FOR HS CODE: 3002, BY COUNTRY, 2020–2024 (TONS)
TABLE 7
EXPORT SCENARIO FOR HS CODE: 3002, BY COUNTRY, 2020–2024 (TONS)
TABLE 8
AVERAGE SELLING PRICE OF POSTBIOTIC PRODUCTS, BY KEY PLAYER, 2024 (USD)
TABLE 9
AVERAGE SELLING PRICE TREND OF POSTBIOTICS, BY REGION, 2021–2024 (USD/KG)
TABLE 10
POSTBIOTIC MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 11
LIST OF MAJOR PATENTS PERTAINING TO POSTBIOTICS MARKET, 2022–2025
TABLE 12
POSTBIOTICS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025–2026
TABLE 13
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
PORTER’S FIVE FORCES IMPACT ON POSTBIOTICS MARKET
TABLE 19
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATIONS
TABLE 20
KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS
TABLE 21
POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 22
POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 23
POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (TONS)
TABLE 24
POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (TONS)
TABLE 25
BACTERIA: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
TABLE 26
BACTERIA: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 27
BACTERIA: POSTBIOTICS MARKET, BY REGION, 2021–2024 (TONS)
TABLE 28
BACTERIA: POSTBIOTICS MARKET, BY REGION, 2025–2030 (TONS)
TABLE 29
BACTERIA: POSTBIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
TABLE 30
BACTERIA: POSTBIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 31
YEAST: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
TABLE 32
YEAST: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 33
YEAST: POSTBIOTICS MARKET, BY REGION, 2021–2024 (TONS)
TABLE 34
YEAST: POSTBIOTICS MARKET, BY REGION, 2025–2030 (TONS)
TABLE 35
YEAST: POSTBIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
TABLE 36
YEAST: POSTBIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 37
POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 38
POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 39
FUNCTIONAL FOOD & BEVERAGES: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
TABLE 40
FUNCTIONAL FOOD & BEVERAGES: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 41
DIETARY SUPPLEMENTS: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
TABLE 42
DIETARY SUPPLEMENTS: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 43
ANIMAL FEED: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
TABLE 44
ANIMAL FEED: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 45
COSMETICS & PERSONAL CARE: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
TABLE 46
COSMETICS & PERSONAL CARE: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 47
PHARMACEUTICALS: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
TABLE 48
PHARMACEUTICALS: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 49
POSTBIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION)
TABLE 50
POSTBIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION)
TABLE 51
DRY: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
TABLE 52
DRY: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 53
LIQUID: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
TABLE 54
LIQUID: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 55
POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
TABLE 56
POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 57
POSTBIOTICS MARKET, BY REGION, 2021–2024 (TONS)
TABLE 58
POSTBIOTICS MARKET, BY REGION, 2025–2030 (TONS)
TABLE 59
NORTH AMERICA: POSTBIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION)
TABLE 60
NORTH AMERICA: POSTBIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 61
NORTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 62
NORTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 63
NORTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (TONS)
TABLE 64
NORTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (TONS)
TABLE 65
NORTH AMERICA: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 66
NORTH AMERICA: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 67
NORTH AMERICA: POSTBIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION)
TABLE 68
NORTH AMERICA: POSTBIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION)
TABLE 69
US: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 70
US: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 71
US: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 72
US: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 73
CANADA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 74
CANADA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 75
CANADA: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 76
CANADA: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 77
MEXICO: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 78
MEXICO: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 79
MEXICO: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 80
MEXICO: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 81
EUROPE: POSTBIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION)
TABLE 82
EUROPE: POSTBIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 83
EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 84
EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 85
EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (TONS)
TABLE 86
EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (TONS)
TABLE 87
EUROPE: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 88
EUROPE: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 89
EUROPE: POSTBIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION)
TABLE 90
EUROPE: POSTBIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION)
TABLE 91
GERMANY: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 92
GERMANY: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 93
GERMANY: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 94
GERMANY: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 95
UK: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 96
UK: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 97
UK: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 98
UK: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 99
FRANCE: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 100
FRANCE: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 101
FRANCE: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 102
FRANCE: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 103
ITALY: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 104
ITALY: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 105
ITALY: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 106
ITALY: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 107
SPAIN: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 108
SPAIN: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 109
SPAIN: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 110
SPAIN: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 111
REST OF EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 112
REST OF EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 113
REST OF EUROPE: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 114
REST OF EUROPE: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 115
ASIA PACIFIC: POSTBIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION)
TABLE 116
ASIA PACIFIC: POSTBIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 117
ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 118
ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 119
ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (TONS)
TABLE 120
ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (TONS)
TABLE 121
ASIA PACIFIC: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 122
ASIA PACIFIC: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 123
ASIA PACIFIC: POSTBIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION)
TABLE 124
ASIA PACIFIC: POSTBIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION)
TABLE 125
CHINA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 126
CHINA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 127
CHINA: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 128
CHINA: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 129
JAPAN: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 130
JAPAN: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 131
JAPAN: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 132
JAPAN: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 133
INDIA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 134
INDIA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 135
INDIA: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 136
INDIA: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 137
AUSTRALIA & NEW ZEALAND: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 138
AUSTRALIA & NEW ZEALAND: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 139
AUSTRALIA & NEW ZEALAND: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 140
AUSTRALIA & NEW ZEALAND: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 141
REST OF ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 142
REST OF ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 143
REST OF ASIA PACIFIC: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 144
REST OF ASIA PACIFIC: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 145
REST OF THE WORLD: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
TABLE 146
REST OF THE WORLD: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 147
REST OF THE WORLD: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 148
REST OF THE WORLD: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 149
REST OF THE WORLD: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (TONS)
TABLE 150
REST OF THE WORLD: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (TONS)
TABLE 151
REST OF THE WORLD: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 152
REST OF THE WORLD: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 153
REST OF THE WORLD: POSTBIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION)
TABLE 154
REST OF THE WORLD: POSTBIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION)
TABLE 155
SOUTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 156
SOUTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 157
SOUTH AMERICA: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 158
SOUTH AMERICA: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 159
MIDDLE EAST: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 160
MIDDLE EAST: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 161
MIDDLE EAST: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 162
MIDDLE EAST: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 163
AFRICA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION)
TABLE 164
AFRICA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 165
AFRICA: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
TABLE 166
AFRICA: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 167
OVERVIEW OF STRATEGIES ADOPTED BY KEY POSTBIOTICS MARKET PLAYERS, 2022–JULY 2025
TABLE 168
PLANT-BASED PROTEIN MARKET: MARKET SHARE ANALYSIS, 2024
TABLE 169
POSTBIOTICS MARKET: REGIONAL FOOTPRINT
TABLE 170
POSTBIOTICS MARKET: SOURCE FOOTPRINT
TABLE 171
POSTBIOTICS MARKET: FORM FOOTPRINT
TABLE 172
POSTBIOTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 173
POSTBIOTICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 174
POSTBIOTICS MARKET: PRODUCT LAUNCHES, JUNE 2022–MARCH 2025
TABLE 175
POSTBIOTICS MARKET: DEALS, DECEMBER 2022–FEBRUARY 2025
TABLE 176
POSTBIOTICS MARKET: EXPANSIONS, FEBRUARY 2020–NOVEMBER 2024
TABLE 177
ADM: COMPANY OVERVIEW
TABLE 178
ADM: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 180
ADM: EXPANSIONS
TABLE 181
ADM: OTHER DEVELOPMENTS
TABLE 182
CARGILL, INCORPORATED: COMPANY OVERVIEW
TABLE 183
CARGILL, INCORPORATED: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 184
CARGILL, INCORPORATED: DEALS
TABLE 185
CARGILL, INCORPORATED: EXPANSIONS
TABLE 186
CARGILL, INCORPORATED: OTHER DEVELOPMENTS
TABLE 187
DSM-FIRMENICH: COMPANY OVERVIEW
TABLE 188
DSM-FIRMENICH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 189
DSM-FIRMENICH: DEALS
TABLE 190
KERRY GROUP PLC: COMPANY OVERVIEW
TABLE 191
KERRY GROUP PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 192
KERRY GROUP PLC: PRODUCT LAUNCHES
TABLE 193
KERRY GROUP PLC: DEALS
TABLE 194
ASSOCIATED BRITISH FOODS PLC: COMPANY OVERVIEW
TABLE 195
ASSOCIATED BRITISH FOODS PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 196
ASSOCIATED BRITISH FOODS PLC: DEALS
TABLE 197
BASF: COMPANY OVERVIEW
TABLE 198
BASF: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 199
BASF: PRODUCT LAUNCHES
TABLE 200
NOVONESIS GROUP: COMPANY OVERVIEW
TABLE 201
NOVONESIS GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 202
INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY OVERVIEW
TABLE 203
INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS/SERVICES/ SOLUTIONS OFFERED
TABLE 204
MCLS EUROPE B.V.: COMPANY OVERVIEW
TABLE 205
MCLS EUROPE B.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 206
PHILEO BY LESAFFRE: COMPANY OVERVIEW
TABLE 207
PHILEO BY LESAFFRE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 208
LALLEMAND INC.: COMPANY OVERVIEW
TABLE 209
LALLEMAND INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 210
LALLEMAND INC.: DEALS
TABLE 211
SAMI-SABINSA GROUP: COMPANY OVERVIEW
TABLE 212
SAMI-SABINSA GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 213
SAMI-SABINSA GROUP: DEALS
TABLE 214
CJ CHEILJEDANG CORP.: COMPANY OVERVIEW
TABLE 215
CJ CHEILJEDANG CORP.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 216
CJ CHEILJEDANG CORP.: PRODUCT LAUNCHES
TABLE 217
CJ CHEILJEDANG CORP.: DEALS
TABLE 218
MORINAGA MILK INDUSTRY CO., LTD.: COMPANY OVERVIEW
TABLE 219
MORINAGA MILK INDUSTRY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 220
KIRIN HOLDINGS COMPANY, LIMITED: COMPANY OVERVIEW
TABLE 221
KIRIN HOLDINGS COMPANY, LIMITED: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 222
KIRIN HOLDINGS COMPANY, LIMITED: OTHER DEVELOPMENTS
TABLE 223
BIOTENOVA SDN. BHD.: COMPANY OVERVIEW
TABLE 224
BIOTENOVA SDN. BHD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 225
BIOTENOVA SDN. BHD.: DEALS
TABLE 226
BIOPROX HEALTHCARE: COMPANY OVERVIEW
TABLE 227
BIOPROX HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 228
SILAB: COMPANY OVERVIEW
TABLE 229
SILAB: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 230
SILAB: EXPANSIONS
TABLE 231
PROBIONIC CORP.: COMPANY OVERVIEW
TABLE 232
PROBIONIC CORP.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 233
NUTRIGNOMIX SDN. BHD.: COMPANY OVERVIEW
TABLE 234
NUTRIGNOMIX SDN. BHD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 235
MARKETS ADJACENT TO POSTBIOTICS MARKET
TABLE 236
FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 237
FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 238
PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION)
TABLE 239
PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION)
FIGURE 1
POSTBIOTICS MARKET: RESEARCH DESIGN
FIGURE 2
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 4
SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP
FIGURE 5
POSTBIOTICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 6
DATA TRIANGULATION
FIGURE 7
POSTBIOTICS MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION)
FIGURE 8
POSTBIOTICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 9
POSTBIOTICS MARKET, BY FORM, 2025 VS. 2030 (USD MILLION)
FIGURE 10
POSTBIOTICS MARKET SHARE AND GROWTH RATE, BY REGION
FIGURE 11
INCREASING DEMAND FOR FORTIFIED AND HEALTH-POSITIONED FOODS AND BEVERAGES TO DRIVE MARKET
FIGURE 12
US AND BACTERIA SEGMENT TO ACCOUNT FOR SIGNIFICANT MARKET SHARES IN 2025
FIGURE 13
BACTERIA SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 14
DRY SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 15
FUNCTIONAL FOOD & BEVERAGES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 16
US TO RECORD LARGEST MARKET SHARE IN 2025
FIGURE 17
POSTBIOTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 18
ADOPTION OF GEN AI IN FOOD & BEVERAGE PRODUCTION PROCESS
FIGURE 19
POSTBIOTICS MARKET: VALUE CHAIN ANALYSIS
FIGURE 20
IMPORT OF HS CODE 3002, BY KEY COUNTRY, 2020–2024 (TONS)
FIGURE 21
EXPORT OF HS CODE 3002, BY KEY COUNTRY, 2020–2024 (TONS)
FIGURE 22
AVERAGE SELLING PRICE OF POSTBIOTIC PRODUCTS, BY KEY PLAYER, 2024 (USD)
FIGURE 23
AVERAGE SELLING PRICE TREND OF POSTBIOTICS, BY REGION, 2021–2024 (USD/KG)
FIGURE 24
POSTBIOTIC MARKET: ECOSYSTEM ANALYSIS
FIGURE 25
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 26
NUMBER OF PATENTS APPLIED AND GRANTED, 2017–2025
FIGURE 27
REGIONAL ANALYSIS OF PATENTS GRANTED FOR POSTBIOTICS
FIGURE 28
POSTBIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 29
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATIONS
FIGURE 30
KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS
FIGURE 31
POSTBIOTIC MARKET: INVESTMENT AND FUNDING SCENARIO
FIGURE 32
POSTBIOTICS MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION)
FIGURE 33
POSTBIOTICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 34
POSTBIOTICS MARKET, BY FORM, 2025 VS. 2030 (USD MILLION)
FIGURE 35
INDIA TO RECORD HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 36
NORTH AMERICA: POSTBIOTICS MARKET SNAPSHOT
FIGURE 37
ASIA PACIFIC: POSTBIOTICS MARKET SNAPSHOT
FIGURE 38
REVENUE ANALYSIS OF KEY MARKET PLAYERS, 2022–2024 (USD BILLION)
FIGURE 39
MARKET SHARE ANALYSIS, 2024
FIGURE 40
COMPANY VALUATION
FIGURE 41
FINANCIAL METRICS
FIGURE 42
POSTBIOTICS MARKET: BRAND/PRODUCT COMPARISON
FIGURE 43
POSTBIOTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 44
POSTBIOTICS MARKET: COMPANY FOOTPRINT
FIGURE 45
POSTBIOTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 46
ADM: COMPANY SNAPSHOT
FIGURE 47
CARGILL, INCORPORATED: COMPANY SNAPSHOT
FIGURE 48
DSM-FIRMENICH: COMPANY SNAPSHOT
FIGURE 49
KERRY GROUP PLC: COMPANY SNAPSHOT
FIGURE 50
ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
FIGURE 51
BASF: COMPANY SNAPSHOT
FIGURE 52
NOVONESIS GROUP: COMPANY SNAPSHOT
FIGURE 53
INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT
FIGURE 54
CJ CHEILJEDANG CORP.: COMPANY SNAPSHOT
FIGURE 55
MORINAGA MILK INDUSTRY CO., LTD.: COMPANY SNAPSHOT
FIGURE 56
KIRIN HOLDINGS COMPANY, LIMITED: COMPANY SNAPSHOT
Growth opportunities and latent adjacency in Postbiotics Market